Thawani, Rajat
Gao, Lina
Mohinani, Ajay
Tudorica, Alina
Li, Xin
Mitri, Zahi
Huang, Wei
Funding for this research was provided by:
National Institutes of Health (U01 CA154602, U01 CA154602)
Article History
Received: 29 March 2022
Revised: 15 September 2022
Accepted: 30 September 2022
First Online: 20 October 2022
Declarations
:
: Oregon Health & Science University (OHSU), Wei Huang, and Xin Li have a significant financial interest in Imbio, LLC, a company that may have a commercial interest in the results of this research and technology. This potential individual and institutional conflict of interest has been reviewed and managed by OHSU.
: Institutional review board approved protocol 5492 at Oregon Health & Science University (Portland, Oregon, U.S.A.). All patients signed a written informed consent was for participation in this study. All methods were carried out in accordance within guidelines and regulations laid down by the institutional review board.